This Wall Street veteran faced breast cancer with determination. After a diagnosis of stage I invasive ductal carcinoma, Jill underwent a lumpectomy and sentinel node biopsy followed by four weeks of hypofractionated radiation therapy. The treatment is given over a shorter period of time compared with standard radiation therapy and can mean less scarring in the area of treatment. Now, Jill says, “I know I had the best care and made the best decisions.”
Karen’s own immune system was her most powerful weapon against chronic lymphocytic leukemia. After participating in a clinical trial studying a new type of immunotherapy, CAR T cell therapy, she is now cancer-free.